USIran Peace Talks Show Progress but Key Disputes Over Uranium and Strait of Hormuz Tolls Remain US Gasoline Demand Expected to Rise as Summer Travel Season Begins Potentially Adding Price Pressure SpaceX Scrub of Starship Test Flight Delays Debut of NextGeneration Rocket Jim Cramer Suggests VF Corporations PostEarnings Dip May Present a Buying Opportunity Q4 Earnings Season Sun Pharma Eicher Motors Lead Gains Hindalco Torrent Pharma See Decline Fed Chair Powell Vows Not to Be Shadow Chair as Historic Overlap with Incoming Chair Warsh Approaches VERX Q1 2026 Earnings Modest EPS Beat Amid Strong Operational Execution Deutsche Bank Q1 2026 Earnings Modest EPS Beat Amid Mixed Market Sentiment Solstice Advanced Materials Inc Q1 2026 Earnings EPS Miss Sent Shares Higher EXFY Q1 2026 Earnings EPS Beats Estimates by 68 as Company Delivers Profitability XPON Q2 2025 Earnings EPS Beats Estimates by 307 Despite Absent Revenue Data CBL Q4 2024 Earnings Massive EPS Surprise Highlights Operational Resilience Hall Chadwick Acquisition Corp Rights HCACR Holds Steady at 029 Sideways Action in a Tight Range Everus Construction Group ECG Nears Support as Momentum Weakens Blackrock Enhanced Global Dividend Trust BOE Hovers Near Support With Minimal Price Change LuxExperience LUXE Gains 284 as Stock Approaches Key Resistance BGT Edges Higher Amid Steady Income Appeal Goldman Sachs Raises SP 500 Target Dismisses Bubble Fears NOMD Q1 2026 Earnings EPS Surges Past Estimates Lifting Shares Banco Bradesco BBDO Shares Decline 159 as Resistance Holds Firm WLFC Q1 2026 Earnings EPS Surges Past Estimates on Strong Leasing Activity BBOT Q1 2026 Earnings NarrowerthanExpected Loss Lifts Sentiment as Stock Declines GYRE Q1 2026 Earnings SmallerthanExpected Loss Drives Positive Surprise Amid Revenue Absence CBOE Q1 2026 Earnings EPS Surges Past Estimates on Strong Trading Activity Voyager Therapeutics Inc VYGR Q1 2026 Earnings Narrowed Loss and Pipeline Progress Support Positive Market Reaction PSX Q1 2026 Earnings Strong Earnings Surprise Driven by Improved Refining Margins OLMA Q1 2026 Earnings NarrowerThanExpected Loss as Clinical Pipeline Advances